Literature DB >> 27955959

What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: A large systematic review and meta-analysis.

Essam Ahmed Al-Moraissi1, Ayed Ali Dahan2, Mohamed Salah Alwadeai3, Fadekemi Olufunmilayo Oginni4, Jamil Mohammed Al-Jamali5, Ahmed Saleh Alkhutari6, Nashwan Hamid Al-Tairi6, Abdulrazaq Ahmed Almaweri7, Jaber Saleh Al-Sanabani7.   

Abstract

PURPOSE: Among the different surgical treatments for keratocystic odontogenic tumors (KOTs), there is no single method associated with a zero recurrence rate (RR). Thus, this study aimed to seek the best surgical treatment with the least RR using a weighted event rated meta-analysis.
MATERIALS AND METHODS: To address our study purpose, a systematic review and meta-analysis based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guideline was performed. An extensive search of major databases through PubMed, EMBASE, and Cochrane CENTRAL was conducted to identify all relevant articles published without language restrictions from inception to August 2016. Relevant articles were selected based on the following inclusion criteria: prospective, retrospective, and case series studies that assessed various treatments in non-syndromic KOTs in which RRs were included. The predictor variable was treatment groups, namely: enucleation alone, enucleation with peripheral ostectomy, enucleation with Carnoy's solution application, enucleation with cryotherapy, marsupialization alone, decompression followed by residual cystectomy, and resection. The outcome variable was RR. A weighted RR using a random effect model (because of variation in follow-up time) with a 95% confidence interval (CI) was performed. Data analysis was performed using a comprehensive meta-analysis software.
RESULTS: A total of 2287 KOTs in 35 studies were included in this analysis. The weighted RR for various treatment techniques was as follows: enucleation alone (23.1%), enucleation with curettage (17.4%), enucleation and Carnoy's solution (11.5%), enucleation plus liquid nitrogen cryotherapy (14.5%), marsupialization alone (32.3%), decompression followed by residual cystectomy (14.6%), and resection (8.4%). The pooled weighted overall RR of KOTs for all different treatments was 16.6%.
CONCLUSION: Radical resection remains the certain option for obtaining the lowest recurrence with KOTs. However, low recurrence accompanies enucleation with application of Carnoy's solution or cryotherapy as the first-line treatment for primary KOTs. Marsupialization (where indicated) must be followed by secondary cystectomy to minimize recurrence. We believe that to achieve the least possible morbidity, resections should be reserved for multiple recurrent lesions and possibly syndromic cases.
Copyright © 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carnoy's solution; Cryotherapy; Keratocystic odontogenic tumor; Meta-analysis; Recurrence rate; Resection

Mesh:

Year:  2016        PMID: 27955959     DOI: 10.1016/j.jcms.2016.10.013

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  19 in total

1.  Recurrence of nonsyndromic odontogenic keratocyst after marsupialization and delayed enucleation vs. enucleation alone: a systematic review and meta-analysis.

Authors:  Yuri Slusarenko da Silva; Paul J W Stoelinga; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-11-29

2.  Expression of keratin 15 in dentigerous cyst, odontogenic keratocyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Alaa Muayad Altaie; Shengrong Zhu
Journal:  Mol Clin Oncol       Date:  2019-01-17

3.  Calculation of postoperative bone healing of cystic lesions of the jaw-a retrospective study.

Authors:  Christoph Sacher; Daniel Holzinger; Paul Grogger; Florian Wagner; Gregor Sperl; Rudolf Seemann
Journal:  Clin Oral Investig       Date:  2019-01-28       Impact factor: 3.573

4.  Therapeutic management of the odontogenic keratocyst. An energetic approach with a conservative perspective and review of the current therapeutic options.

Authors:  Jordi Borrás-Ferreres; Alba Sánchez-Torres; Javier Alberdi-Navarro; José-Manuel Aguirre-Urizar; Adalberto Mosqueda-Taylor; Cosme Gay-Escoda
Journal:  J Clin Exp Dent       Date:  2020-08-01

5.  Topical 5-fluorouracil application in management of odontogenic keratocysts.

Authors:  Parveen Akhter Lone; Nisar Ahmed Wani; Zubair Ahmed Janbaz; Mehnaz Bibi; Amit Kour
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-22

Review 6.  An evidence-based surgical algorithm for management of odontogenic keratocyst.

Authors:  Fadekemi Olufunmilayo Oginni; Nasser Alasseri; Oladunni Mojirayo Ogundana; Bamidele Adetokunbo Famurewa; Anthony Pogrel; Essam Ahmed Al-Moraissi
Journal:  Oral Maxillofac Surg       Date:  2022-04-27

7.  Differentiation of cystic lesions in the jaw by conventional magnetic resonance imaging and diffusion-weighted imaging.

Authors:  Natnicha Wamasing; Hiroshi Watanabe; Junichiro Sakamoto; Hiroshi Tomisato; Tohru Kurabayashi
Journal:  Dentomaxillofac Radiol       Date:  2021-06-16       Impact factor: 2.419

8.  Long-term observation of a large keratocystic odontogenic tumour of the mandible treated by a single enucleation procedure: A case report and literature review.

Authors:  Tobias L Pittl; Marius Meier; Paul Hakl; Walter Sutter; Dritan Turhani
Journal:  Int J Surg Case Rep       Date:  2017-03-23

9.  Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts.

Authors:  Tomasz Kaczmarzyk; Konrad Kisielowski; Rafał Koszowski; Magdalena Rynkiewicz; Ewa Gawełek; Karolina Babiuch; Anna Bednarczyk; Bogna Drozdzowska
Journal:  Clin Oral Investig       Date:  2018-03-05       Impact factor: 3.573

10.  Eruption of the Permanent First Premolar Associated with a Mandibular Keratocystic Odontogenic Tumor after Marsupialization in a 9-year-old Boy: A Case Report with 2 years of follow-up.

Authors:  Nima Farshidfar; Mahya Agharokh; Hossein Daneste
Journal:  J Dent (Shiraz)       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.